169 related articles for article (PubMed ID: 25195148)
1. A polymorphism at miRNA-122-binding site in the IL-1α 3'UTR is associated with risk of epithelial ovarian cancer.
Zhang Z; Zhou B; Gao Q; Wu Y; Zhang K; Pu Y; Song Y; Zhang L; Xi M
Fam Cancer; 2014 Dec; 13(4):595-601. PubMed ID: 25195148
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of IL-27 polymorphisms and the susceptibility to epithelial ovarian cancer in a Chinese population.
Zhang Z; Zhou B; Wu Y; Gao Q; Zhang K; Song Y; Zhang L; Xi M
Immunogenetics; 2014 Feb; 66(2):85-92. PubMed ID: 24352695
[TBL] [Abstract][Full Text] [Related]
3. A functional variant at miRNA-122 binding site in IL-1α 3' UTR predicts risk and HPV-positive tumours of oropharyngeal cancer.
Zhang Y; Sturgis EM; Sun Y; Sun C; Wei Q; Huang Z; Li G
Eur J Cancer; 2015 Jul; 51(11):1415-23. PubMed ID: 25981582
[TBL] [Abstract][Full Text] [Related]
4. An insertion/deletion polymorphism at the microRNA-122 binding site in the interleukin-1α 3'-untranslated region is associated with a risk for osteoarthritis.
Yang F; Hu A; Zhao D; Guo L; Yang L; Wang B; Tian F; Liu B; Huang S; Xie H
Mol Med Rep; 2015 Oct; 12(4):6199-206. PubMed ID: 26239639
[TBL] [Abstract][Full Text] [Related]
5. A functional variant at miRNA-122 binding site in IL-1a 3' UTR predicts risk of recurrence in patients with oropharyngeal cancer.
Wang C; Sturgis EM; Chen X; Wei Q; Li G
Oncotarget; 2016 Jun; 7(23):34472-9. PubMed ID: 27121322
[TBL] [Abstract][Full Text] [Related]
6. 4-bp insertion/deletion (rs3783553) polymorphism within the 3'UTR of IL1A contributes to the risk of prostate cancer in a sample of Iranian population.
Hashemi M; Bahari G; Sarhadi S; Eskandari E; Narouie B; Taheri M; Ghavami S
J Cell Biochem; 2018 Mar; 119(3):2627-2635. PubMed ID: 29023981
[TBL] [Abstract][Full Text] [Related]
7. An insertion/deletion polymorphism in the interleukin-1A 3'untranslated region confers risk for gastric cancer.
Zhang J; Shi H; Xue M; Yu Q; Yang L; Zheng S; Zhou C
Cancer Biomark; 2016; 16(3):359-65. PubMed ID: 26889982
[TBL] [Abstract][Full Text] [Related]
8. Genetic Association of Interleukin-31 Gene Polymorphisms with Epithelial Ovarian Cancer in Chinese Population.
Liu C; Wang Y; Song H; Li Q; Zhang Y; Chen P; Song Y; Su M; Huang Q; Wang M; Zhou B; Zhang L
Dis Markers; 2018; 2018():3503858. PubMed ID: 29484036
[TBL] [Abstract][Full Text] [Related]
9. nm23 gene polymorphisms are associated with survival of patients with epithelial ovarian cancer but not with susceptibility to disease.
Li Y; Kang S; Qin JJ; Wang N; Zhou RM; Sun HY
Gynecol Oncol; 2012 Sep; 126(3):455-9. PubMed ID: 22683585
[TBL] [Abstract][Full Text] [Related]
10. HLA-G 3' untranslated region variants +3187G/G, +3196G/G and +3035T define diametrical clinical status and disease outcome in epithelial ovarian cancer.
Schwich E; Rebmann V; Michita RT; Rohn H; Voncken JW; Horn PA; Kimmig R; Kasimir-Bauer S; Buderath P
Sci Rep; 2019 Apr; 9(1):5407. PubMed ID: 30932005
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological and prognostic implications of the miR-200 family in patients with epithelial ovarian cancer.
Cao Q; Lu K; Dai S; Hu Y; Fan W
Int J Clin Exp Pathol; 2014; 7(5):2392-401. PubMed ID: 24966949
[TBL] [Abstract][Full Text] [Related]
12. Functional polymorphism rs3783553 in the 3'-untranslated region of IL-1A increased the risk of ischemic stroke: A case-control study.
Wang P; He Q; Liu C; He SZ; Zhu SY; Li YW; Su W; Xiang ST; Zhao B
Medicine (Baltimore); 2017 Nov; 96(46):e8522. PubMed ID: 29145255
[TBL] [Abstract][Full Text] [Related]
13. Association of miRNA-122-binding site polymorphism at the interleukin-1 α gene and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
Du Y; Han X; Pu R; Xie J; Zhang Y; Cao G
Front Med; 2014 Jun; 8(2):217-26. PubMed ID: 24748463
[TBL] [Abstract][Full Text] [Related]
14. Targeted resequencing of the microRNAome and 3'UTRome reveals functional germline DNA variants with altered prevalence in epithelial ovarian cancer.
Chen X; Paranjape T; Stahlhut C; McVeigh T; Keane F; Nallur S; Miller N; Kerin M; Deng Y; Yao X; Zhao H; Weidhaas JB; Slack FJ
Oncogene; 2015 Apr; 34(16):2125-37. PubMed ID: 24909162
[TBL] [Abstract][Full Text] [Related]
15. A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer.
Ratner ES; Keane FK; Lindner R; Tassi RA; Paranjape T; Glasgow M; Nallur S; Deng Y; Lu L; Steele L; Sand S; Muller RU; Bignotti E; Bellone S; Boeke M; Yao X; Pecorelli S; Ravaggi A; Katsaros D; Zelterman D; Cristea MC; Yu H; Rutherford TJ; Weitzel JN; Neuhausen SL; Schwartz PE; Slack FJ; Santin AD; Weidhaas JB
Oncogene; 2012 Oct; 31(42):4559-66. PubMed ID: 22139083
[TBL] [Abstract][Full Text] [Related]
16. Roles of functional NFKB1 and β-TrCP insertion/deletion polymorphisms in mRNA expression and epithelial ovarian cancer susceptibility.
Huo ZH; Zhong HJ; Zhu YS; Xing B; Tang H
Genet Mol Res; 2013 Mar; 12(3):3435-43. PubMed ID: 23546975
[TBL] [Abstract][Full Text] [Related]
17. A functional polymorphism in interleukin-1α (IL1A) gene is associated with risk of alopecia areata in Chinese populations.
Lu D; Chen L; Shi X; Zhang X; Ling X; Chen X; Xie L; Jiang L; Ding L; He Y; Zhang X
Gene; 2013 Jun; 521(2):282-6. PubMed ID: 23542780
[TBL] [Abstract][Full Text] [Related]
18. Expression of hypoxia-inducible factor 1alpha gene affects the outcome in patients with ovarian cancer.
Shimogai R; Kigawa J; Itamochi H; Iba T; Kanamori Y; Oishi T; Shimada M; Sato S; Kawaguchi W; Sato S; Terakawa N
Int J Gynecol Cancer; 2008; 18(3):499-505. PubMed ID: 18476949
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of Abelson interactor protein 1 predicts tumor progression and poor outcome in epithelial ovarian cancer.
Zhang J; Tang L; Chen Y; Duan Z; Xiao L; Li W; Liu X; Shen L
Hum Pathol; 2015 Sep; 46(9):1331-40. PubMed ID: 26193797
[TBL] [Abstract][Full Text] [Related]
20. Correlation of HLA-A02* genotype and HLA class I antigen down-regulation with the prognosis of epithelial ovarian cancer.
Andersson E; Villabona L; Bergfeldt K; Carlson JW; Ferrone S; Kiessling R; Seliger B; Masucci GV
Cancer Immunol Immunother; 2012 Aug; 61(8):1243-53. PubMed ID: 22258792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
